Sacral nerve stimulation (SNS) is a medical electrical stimulation therapy that is used to treat long-term bowel control and bladder control symptoms through the modulation of nerves controlling the lower urinary tract and pelvic floor.



Scope of the Report:

This report focuses on the Sacral Nerve Stimulation Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The external SNS device is one of the fastest growing product segments in the global sacral nerve stimulation market. Although there is just one external device available in the market, it is FDA approved and has the CE mark. However, this device is completely new to the market in APAC as implantable SNS devices are more popular compared with external SNS devices. With the introduction of new SNS devices by companies such as Nuvectra and Axonics Modulation Technologies, this segment is anticipated to have a positive outlook in the coming years.

The hospitals segment was the highest revenue contributing segment in the sacral nerve stimulation market. The complexity of the device, the need for technical expertise, and high procedure cost are some of the factors that will promote the increased adoption of SNS devices in hospitals.

The worldwide market for Sacral Nerve Stimulation Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.



Market Segment by Manufacturers, this report covers

Medtronic

Boston Scientific

St. Jude Medical

Axonics Modulation Technologies

Nuvectra

Cogentix Medical

Cyberonics

Uroplasty, Inc

Neuropace

IntraPace, Inc

Codman & Shurtleff, Inc



Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)



Market Segment by Type, covers

Implantable SNS Devices

External SNS Devices



Market Segment by Applications, can be divided into

Hospitals

Clinics

ASCs



There are 15 Chapters to deeply display the global Sacral Nerve Stimulation Devices market.

Chapter 1, to describe Sacral Nerve Stimulation Devices Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Sacral Nerve Stimulation Devices, with sales, revenue, and price of Sacral Nerve Stimulation Devices, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Sacral Nerve Stimulation Devices, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Sacral Nerve Stimulation Devices market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Sacral Nerve Stimulation Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source